Showing presentation: reset
Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Efficacy and safety results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial
- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: Efficacy and safety results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial
Alexander M Eggermont
Gustave Roussy Cancer Campus Grand Paris & University Paris-Saclay, Villejuif, France